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TransplantationThe patient is a 61-year-old male with a diagnosis of relapse classical Hodgkin lymphoma, treated with ABVD,
ICE, and achieved remission. He underwent autologous stem cell transplantation and 3 months later found to
have a PET-positive neck node concerning for relapsed disease of Hodgkin lymphoma. Biopsy proved the lesion
was HPV-associated squamous cell carcinoma and not relapse Hodgkin disease. Iatrogenic immunosuppression
such as bone marrow transplantation can cause substantial increase risk for viral-associated tumors and there-
fore tissue biopsies are necessary to make that distinction to avoid inappropriate treatment.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/)1. Introduction
Secondary malignant neoplasms after bone marrow transplantation
are a known long-term complication which can be caused by various
mechanisms, depending on the type of transplant. In allogeneic hema-
topoietic cell transplantations (HCT), secondary neoplasms can be
caused by immunosuppression which allows oncogenic viruses to pro-
liferate in vulnerable cells [1–3]. For autologous HCT secondary neo-
plasms are less frequent and are usually secondary to the
chemotherapy or radiation therapy [4,5]. The latency period for the de-
velopment of a secondary malignancy after autologous transplantation
is usually greater than 10 years (cumulative risk of 6% at 10 years and
15% at 15 years post-transplantation) [6]. Herein,we present an unusual
patient with classical Hodgkin lymphoma who developed squamous
cell carcinoma of the oral cavity three months after autologous HCT.2. Case report
The patient is a 61-year-old male with a diagnosis of classical Hodg-
kin lymphoma (HL) (Fig. 1A), who presented with stage IVB diseaseCity of Hope National Medical
States.
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risk international prognostic factors including age, male sex, stage IV,
and hypoalbuminemia. He was treated with doxorubicin, bleomycin,
vinblastine, and dacarbazine (ABVD) for 6 cycles but had progression
of the disease within a month after completion of ABVD. Repeat
lymph node biopsy conﬁrmed relapsed HL. He was then given
ifosfamide, carboplatin, and etoposide (ICE) × 2 cycles andwent into re-
mission. He underwent autologous HCT using yttrium 90-labeled anti-
CD25 antibody in combination with high-dose carmustine, etoposide,
cytarabine, andmelphalan (BEAM) regimen. A follow-up positron emis-
sion tomography-computed (PET) scan at 3months post-HCT showed a
solitary lymph node in the right neck measuring 16 × 14 mm with a
standardized uptake value (SUV) of 10.4 (Fig. 1B), which was
concerning for relapsed disease. No other lymphadenopathy was
noted. An excisional biopsy was performed and showed squamous cell
carcinoma (Fig. 1C) in a 2.2 × 1.8 × 1.5 cm lymph node that was positive
for cytokeratin, p16, a surrogate marker for human papillomavirus [7]
(Fig. 1C, inset), and p63 by immunohistochemical staining. This proﬁle
raised concern for an HPV-mediated oropharyngeal cancer as a second
primarymalignancy present. Further investigation showed an ipsilater-
al base of tongue lesion proven to be the primary cancer by diagnostic
laryngoscopy and biopsy. Deﬁnitive surgical management included
base of tongue resection by transoral robotic surgery (TORS) and also
modiﬁed radical neck dissection. Pathologic evaluation showed a p16-
positive squamous cell carcinoma of the base of the tongue whichthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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Fig. 1. A. Lymph node showing scattered Hodgkin and Reed-Sternberg cells (arrows, Hematoxylin and eosin stain). B. Follow-up PET scan after bone marrow transplantation shows a
solitary lymph node with increased uptake (SUV 10) in the right neck. C. Excisional biopsy of the lymph node shows squamous cell carcinoma (Hematoxylin and eosin stain) that was
also positive for p16 (inset) by immunohistochemistry. D. PET scan prior to transplantation showed the same solitary node but with SUV 4.7.
2 J.Y. Song et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxmeasured 1.9 cmwith a depth of invasion of 9 mm (T1). The closest re-
section margin was the deep margin at 2 mm. The neck dissection
yielded another involved lymphnodemeasuring 1.0 cmandwith no ev-
idence for extracapsular extension (N2b). Final pathology stage was
IVA, therefore adjuvant radiation therapy was given. A dose of 60 Gy
over 30 fractions was delivered to the surgical bed in the right base of
tongue and pathologically involved nodal stations in the right neck.
The contralateral neck received a dose of 54 Gy over 30 fractions using
dose painting IMRT technique. Patient is currently doing well
8 months following completion of the treatment and 1 year after trans-
plant. His most recent PET/CT scan was negative.
3. Materials and methods
Formalin-ﬁxed, parafﬁn-embedded tissue from the patient's sample
was cut at 4 μm thickness, deparafﬁnized in xylene, and hydrated using
serial percentages of alcohol. A hematoxylin and eosin stain was per-
formed on the sections. Immunostains were also performed using anti-
bodies for CD30 (clone JCM182, Leica), cytokeratin Oscar (clone Oscar,
Cell Marque), PAX5 (clone 1EW, Leica), CD15 (clone MMA, BD Biosci-
ence), p53 (clone 7JUL, Leica), and p16 (clone G175-405, Ventana). All
stains were performed on the BOND immunostainer by Leica (Buffalo
Grove, IL, USA) using a ready to use dilution.
4. Discussion
This case is of interest for three reasons: 1) the rapid clinical presen-
tation of a secondary malignancy only three months after HCT, 2) the
possibility that recurrent lymphadenopathy may not always be due to
relapsed disease but may represent other pathology including second
malignancy and 3) in an adult middle-aged male who presents with
an abnormal neck node a head and neck aerodigestive primary shouldPlease cite this article as: J.Y. Song, et al., Rapid development of HPV-media
suppression following autologous ..., Human Path Case Reports (2016), htalways be considered even in a nonsmoker. HPV-mediated oropharyn-
geal squamous cell carcinoma is a growing cancer demographic in this
country. Today up to 70% of oropharyngeal cancer cases diagnosed in
the United States are HPV mediated. Immune suppression such as that
following bone marrow transplantation may increase susceptibility to
HPV-mediated cancers including those that arise in the aerodigestive
tract.
In summary, patients with iatrogenic immunosuppression due to
organ or bone marrow transplantation are at a substantial risk for
viral-associated tumors such as Epstein-Barr virus-associated lympho-
mas, as well as HPV-associated cancers involving the vulva, vagina,
anus, and oropharynx [8–10]. This case underscores the importance of
a careful physical examination, imaging review, and heightened alert-
ness regarding synchronous malignancies inpatients being evaluated
for bone marrow transplantation. HPV-mediated oropharyngeal squa-
mous cell carcinoma (HPV-OPSCC) predominately involves the palatine
and/or lingual tonsillar tissues and is not uncommon, especially in
middle-aged males. HPV-OPSCC is associated with improved prognosis
for overall and disease speciﬁc survival compared to tobacco mediated
oropharyngeal cancers [11,12]. If this lesion had not been biopsied
after the PET scan for diagnosis, the presumptive diagnosis of persistent
Hodgkin lymphoma would have led to mismanagement.References
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